Govt panel recommends permission for phase 3 trial of Sputnik Light vaccine as booster dose: An expert panel of India's central drug authority has recommended the permission for conducting phase-3 clinical trial of single-dose COVID-19 vaccine 'Sputnik Light' as a booster dose, official sources said on Saturday. The recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval. The DCGI had on February 4 granted emergency use permission to Sputnik Light vaccine in India, subject to certain regulatory provisions. Hyderabad-based Dr. Reddy's Laboratories had presented its proposal to DCGI for conducting the phase-3 trial of Sputnik Light vaccine as booster dose. Sputnik Light is the same as component-1 of Sputnik V. Sputnik Light vaccine is approved in 29 countries, including Argentina and Russia.
Download JPEG • 19KB